Role of beta-cell dysfunction, ectopic fat accumulation and insulin resistance in the pathogenesis of type 2 diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 93, Issue SUPPL. 1, 2011, Pages

  Gastaldelli, Amalia ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Beta cells; Diabetes mellitus type 2; Ectopic fat; Insulin resistance

Indexed keywords

FATTY ACID;

ARTICLE; DISEASE COURSE; DISEASE SEVERITY; FASTING HYPERGLYCEMIA; FOOD INTAKE; GLUCOSE HOMEOSTASIS; GLUCOSE SENSITIVITY; GLUCOSE TOLERANCE; GLYCOGENOLYSIS; HORMONE SENSITIVITY; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; LIPID STORAGE; LIPOLYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PANCREAS ISLET DISEASE; PATHOGENESIS; POSTPRANDIAL HYPERGLYCEMIA;

ANIMALS; CARBOHYDRATE METABOLISM; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LIPID METABOLISM;

EID: 84860420859     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/S0168-8227(11)70015-8     Document Type: Article

References (40)

1. Defronzo RA Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 2009, 58:773-795.
2. Lebovitz HE Type 2 diabetes: an overview. Clin Chem 1999, 45:1339-1345.
3. Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, DeFronzo RA Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia 2004, 47:31-39.
4. Gastaldelli A, Miyazaki Y, Pettiti M, Buzzigoli E, Mahankali S, Ferrannini E, et al. Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis. J Clin Endocrinol Metab 2004, 89:3914-3921.
5. Gastaldelli A, Baldi S, Pettiti M, Toschi E, Camastra S, Natali A, et al. Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes 2000, 49:1367-1373.
6. Gerich JE, Meyer C, Woerle HJ, Stumvoll M Renal gluconeogenesis: its importance in human glucose homeostasis. Diabetes Care 2001, 24:382-391.
7. Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, et al. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology 2007, 133:496-506.
8. Gastaldelli A, Miyazaki Y, Pettiti M, Matsuda M, Mahankali S, Santini E, et al. Metabolic effects of visceral fat accumulation in type 2 diabetes. J Clin Endocrinol Metab 2002, 87:5098-5103.
9. Gastaldelli A, Casolaro A, Pettiti M, Nannipieri M, Ciociaro D, Frascerra S, et al. Effect of pioglitazone on the metabolic and hormonal response to a mixed meal in type II diabetes. Clin Pharmacol Ther 2007, 81:205-212.
10. Ferrannini E, Mari A Beta cell function and its relation to insulin action in humans: a critical appraisal. Diabetologia 2004, 47:943-956.
11. Ferrannini E, Camastra S, Gastaldelli A, Maria Sironxi A, Natali A, Muscelli E, et al. Beta-cell function in obesity: effects of weight loss. Diabetes 2004, 53(Suppl 3):S26-S33.
12. Marchetti P, Dotta F, Lauro D, Purrello F An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment. Regul Pept 2008, 146:4-11.
13. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003, 52:102-110.
14. Kahn SE The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 2003, 46:3-19.
15. Del Prato S, Marchetti P Beta- and alpha-cell dysfunction in type 2 diabetes. Horm Metab Res 2004, 36:775-781.
16. Cersosimo E, Gastaldelli A, Cervera A, Wajcberg E, Sriwijilkamol A, Fernandez M, et al. Effect of Exenatide on Splanchnic and Peripheral Glucose Metabolism in Type 2 Diabetic Subjects. J Clin Endocr Metab 2011, First published ahead of print March 16, 2011 as doi:10.1210/jc.2010-2146.
17. DeFronzo RA Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988, 37:667-687.
18. Iozzo P, Jarvisalo MJ, Kiss J, Borra R, Naum GA, Viljanen A, et al. Quantification of liver glucose metabolism by positron emission tomography: validation study in pigs. Gastroenterology 2007, 132:531-542.
19. Bays H, Mandarino L, DeFronzo RA Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab 2004, 89:463-478.
20. Boden G, Lebed B, Schatz M, Homko C, Lemieux S Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 2001, 50:1612-1617.
21. Schmitz-Peiffer C Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply. Cell Signal 2000, 12:583-594.
22. Boden G, Cheung P, Stein TP, Kresge K, Mozzoli M FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis. Am J Physiol Endocrinol Metab 2002, 283:E12-E19.
23. Bergman RN, Mittelman SD Central role of the adipocyte in insulin resistance. J Basic Clin Physiol Pharmacol 1998, 9:205-221.
24. Boden G, Chen X, Rosner J, Barton M Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes 1995, 44:1239-1242.
25. Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W, et al. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 2003, 52:2461-2474.
26. Gastaldelli A, Toschi E, Pettiti M, Frascerra S, Quinones-Galvan A, Sironi AM, et al. Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients. Diabetes 2001, 50:1807-1812.
27. Gastaldelli A, Baldi S, Pettiti M, Toschi E, Camastra S, Natali A, et al. Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes 2000, 49:1367-1373.
28. Paquot N, Scheen AJ, Dirlewanger M, Lefebvre PJ, Tappy L Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients. Obes Res 2002, 10:129-134.
29. Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 1996, 45:633-638.
30. Bugianesi E, Gastaldelli A, Vanni E, Gambino R, Cassader M, Baldi S, et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 2005, 48:634-642.
31. Boden G, Shulman GI Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 2002, 32(Suppl 3):14-23.
32. Ferrannini E, Sironi AM, Iozzo P, Gastaldelli A Intra-abdominal adiposity, abdominal obesity, and cardiometabolic risk. Eur Heart J Suppl 2008, 10:B4-10.
33. Moro C, Bajpeyi S, Smith SR Determinants of intramyocellular triglyceride turnover: implications for insulin sensitivity. Am J Physiol Endocrinol Metab 2008, 294:E203-E213.
34. Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Jarvinen H Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. Gastroenterology 2008, 135:122-130.
35. Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD Splanchnic lipolysis in human obesity. J Clin Invest 2004, 113:1582-1588.
36. Boden G Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes. Exp Clin Endocrinol Diabetes 2003, 111:121-124.
37. Cusi K, Kashyap S, Gastaldelli A, Bajaj M, Cersosimo E Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes. Am J Physiol Endocrinol Metab 2007, 292:E1775-E1781.
38. Lingvay I, Esser V, Legendre JL, Price AL, Wertz KM, Adams-Huet B, et al. Noninvasive quantification of pancreatic fat in humans. J Clin Endocrinol Metab 2009, 94:4070-4076.
39. Tushuizen ME, Bunck MC, Pouwels PJ, Bontemps S, van Waesberghe JH, Schindhelm RK, et al. Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes Care 2007, 30:2916-2921.
40. Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA Beta-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab 2005, 90:493-500.